Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
San-fu Herbal Patch and Moxibustion for Persistent Allergic Rhinitis
NCT02580682Phase 2Unknown
- Start
- Jul 2016
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in persistent allergic rhinitis (PAR) (4 arms). Primary endpoint: Total Nasal Symptom Score at 3 years. Status: unknown.
02
Conditions
persistent allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT02580682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02580682.